Management of Helicobacter pylori Infection

作者: Marko Duvnjak , Ivan Lerotić

DOI: 10.1007/978-1-4419-1730-0_9

关键词: Transmission (medicine)PopulationRisk factorAsymptomaticMedicineInternal medicineHelicobacter pyloriChronic gastritisStomachDisease

摘要: The discovery of Helicobacter pylori (H. pylori) in 1982 by Barry Marshall and Robin Warren was the starting point a new era understanding management gastroduodenal diseases. H. is spiral-shaped, gram-negative, microaerophilic, urease-producing bacterium. It one most common human infections worldwide, it estimated that about half world’s population infected [1]. risk acquiring infection related to socioeconomic status, living conditions, habits we acquire from early childhood. Person-to-person transmission through either fecal-to-oral or oral-to-oral exposure seems be probable way infection. In developing nations, where majority children are before age 10, prevalence adults exceeds 80% developed countries, detection unusual but becomes more during adulthood, increases up 50% elderly Approximately 30% 40% United States (US) with [2]. North America, among Asian Americans, African Hispanics similar found countries [3]. Once acquired, persists stomach for years may not produce disease. Over individuals bacterium asymptomatic. However, main factor broad variety chronic gastrointestinal diseases such as gastritis, peptic ulcer disease, gastric adenocarcinoma, mucosa-associated lymphoid tissue (MALT) lymphoma.

参考文章(175)
Elizabeth S. DeLyria, Raymond W. Redline, Thomas G. Blanchard, Vaccination of Mice Against H pylori Induces a Strong Th-17 Response and Immunity That Is Neutrophil Dependent Gastroenterology. ,vol. 136, pp. 247- 256 ,(2009) , 10.1053/J.GASTRO.2008.09.017
Irène Corthésy-Theulaz, Nadine Porta, Micheline Glauser, Emilia Saraga, Anne-Catherine Vaney, Rainer Haas, Jean-Pierre Kraehenbuhl, AndréL. Blum, Pierre Michetti, Oral immunization with Helicobacter pylori urease B subunit as a treatment against Helicobacter infection in mice Gastroenterology. ,vol. 109, pp. 115- 121 ,(1995) , 10.1016/0016-5085(95)90275-9
Robertino Mera, Elizabeth TH Fontham, Luis Eduardo Bravo, Juan Carlos Bravo, Maria Blanca Piazuelo, Maria Constanza Camargo, Pelayo Correa, Long term follow up of patients treated for Helicobacter pylori infection Gut. ,vol. 54, pp. 1536- 1540 ,(2005) , 10.1136/GUT.2005.072009
Suja DuBois, David J. Kearney, Iron-deficiency anemia and Helicobacter pylori infection: a review of the evidence. The American Journal of Gastroenterology. ,vol. 100, pp. 453- 459 ,(2005) , 10.1111/J.1572-0241.2005.30252.X
William D. Chey, D. C. Metz, J. Montague, U. Murthy, S. Shaw, D. Kearney, Appropriate timing of the 14C-urea breath test to establish eradication of Helicobacter pylori infection The American Journal of Gastroenterology. ,vol. 95, pp. 1171- 1174 ,(2000) , 10.1016/S0002-9270(00)00797-8
Emad M El–Omar, Karin Oien, Lilian S Murray, Adil El–Nujumi, Angela Wirz, Derek Gillen, Craig Williams, Grant Fullarton, Kenneth EL McColl, None, Increased prevalence of precancerous changes in relatives of gastric cancer patients : Critical role of H. pylori Gastroenterology. ,vol. 118, pp. 22- 30 ,(2000) , 10.1016/S0016-5085(00)70410-0
M. A. Staat, D. Kruszon-Moran, G. M. McQuillan, R. A. Kaslow, A Population-Based Serologic Survey of Helicobacter pylori Infection in Children and Adolescents in the United States The Journal of Infectious Diseases. ,vol. 174, pp. 1120- 1123 ,(1996) , 10.1093/INFDIS/174.5.1120
Lorenzo Fuccio, Maria Eugenia Minardi, Rocco Maurizio Zagari, Diego Grilli, Nicola Magrini, Franco Bazzoli, Meta-analysis: Duration of First-Line Proton-Pump Inhibitor–Based Triple Therapy for Helicobacter pylori Eradication Annals of Internal Medicine. ,vol. 147, pp. 553- 562 ,(2007) , 10.7326/0003-4819-147-8-200710160-00008
Loren Laine, Jennifer Sugg, Lisa Suchower, Garry Neil, Endoscopic biopsy requirements for post-treatment diagnosis of Helicobacter pylori Gastrointestinal Endoscopy. ,vol. 51, pp. 664- 669 ,(2000) , 10.1067/MGE.2000.105776
Z.Z Nurgalieva, D.Y Graham, Pearls and pitfalls of assessing Helicobacter pylori status. Digestive and Liver Disease. ,vol. 35, pp. 375- 377 ,(2003) , 10.1016/S1590-8658(03)00166-X